US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist
  • 0.635
  • -0.015-2.25%
Close Dec 20 16:00 ET
  • 0.648
  • +0.013+2.09%
Post 20:01 ET
80.13MMarket Cap-0.60P/E (TTM)

Karyopharm Therapeutics Key Stats

Karyopharm Therapeutics Q3 2024 Earnings Date

Currency:USDNov 5, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
37.92M
38.78M
+859.00K
Beat Est.
+5.32%
+7.70%
+2.27%
EPS
-0.29
-0.26
+0.03
Beat Est.
+1.67%
+13.33%
+11.83%
Strong Buy

Nov 30, 2024

Karyopharm Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 45.712M--
--2024/Q4-- / 38.195M--
Nov 5, 20242024/Q338.783M / 37.924M--
Aug 6, 20242024/Q242.786M / 36.213M--
May 8, 20242024/Q133.126M / 34.473M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 45.712M--
--2024/Q4-- / 38.195M--
Nov 5, 20242024/Q338.783M / 37.924M--
Aug 6, 20242024/Q242.786M / 36.213M--
May 8, 20242024/Q133.126M / 34.473M--

Unlock Free Earnings Estimates

Karyopharm Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Nov 30, 2024

Strong Buy

  • Buy

    83.33%
  • Hold

    16.67%
  • Sell

    0.00%

Price Target

No Data